First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial-Reference-Cited by-同舟云学术

First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial

Published:2006-03 Issue:3 Volume:64 Page:342-351
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Colao Annamaria,Pivonello Rosario,Rosato Francesca,Tita Patrizia,Menis Ernesto,Barreca Antonina,Ferrara Roberto,Mainini Franco,Arosio Maura,Lombardi Gaetano

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2006.02467.x/fullpdf

Reference29 articles.

1. Growth-hormone and prolactin excess

2. EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION

3. ACROMEGALY

4. Epidemiology and Long-term Survival in Acromegaly: A Study of 166 Cases Diagnosed between 1955 and 1984

5. Determinants of clinical outcome and survival in acromegaly

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical treatment of acromegaly – When the tumor size matters: A narrative review;Growth Hormone & IGF Research;2024-10

2. Surgical-pharmacological interactions in the treatment of acromegaly;Expert Review of Endocrinology & Metabolism;2018-12-29

3. The efficacy of medical treatment in patients with acromegaly in clinical practice;Endocrine Journal;2018

4. Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center;Pituitary;2016-05-07

5. Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly;Nutrition, Metabolism and Cardiovascular Diseases;2016-02